• $135.7M
    Market Cap
  • 40.09%
    1-Year Change
  • Specialty Chemicals
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 65
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength

Several companies are transitioning from strategic announcements to operational execution. Kraig Biocraft Laboratories has begun production of recombinant spider silk and received National Geographic cover feature. Rackspace and Palantir announced a strategic partnership to deploy enterprise AI in production environments. Ensysce Biosciences initiated a formal strategic review to explore partnerships and enhance shareholder value.

02/27/2026, 9:45 AM • GlobeNewswire

$30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum

Small- and mid-cap stocks are gaining momentum on execution milestones and transformative deals. Interactive Strength surged 40% after acquiring Ergatta to boost revenue guidance by 50%. Kraig Biocraft Laboratories activated its 2026 production program for spider silk manufacturing. Theriva Biologics out-licensed an asset to focus on its pancreatic cancer program, while PMGC Holdings' subsidiary filed patents for animal health applications.

02/19/2026, 11:00 AM • GlobeNewswire

Electrify, Simplify, Spin-Off & Scale

Several companies announced significant developments in electrification, materials technology, industrial restructuring, and AI infrastructure, including partnerships, strategic sales, and infrastructure expansion.

11/21/2025, 10:00 AM • GlobeNewswire

Strong Earnings and Biotech Resilience Define the Midweek Momentum

Several biotech companies reported significant developments, including Kraig Labs' breakthrough in spider silk production, Salarius Pharmaceuticals' public offering, Humacyte's Q3 progress, and CorMedix's record quarterly earnings.

11/12/2025, 11:00 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$0.12
$0.13
$0.13
1-Year Range
$0.08
$0.16
$0.13
Latest Close$0.13
Change
+$0.005 (+3.65%)
Volume1,511,123
Market Cap$135.7M
Shares Outstanding1.1B
P/E (TTM)32.95
Diluted EPS (TTM)$0.004
Enterprise Value$135.9M

Information as of 06/02/2026

Company Profile

Kraig Biocraft Laboratories, Inc.
https://www.kraiglabs.com
$135.7M
Market Cap
$4.0M
Net Income
Sector: Basic Materials
Industry: Specialty Chemicals
2723 South State Street, Ann Arbor, MI, United States, 48104
734 619 8066

Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. The company's primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; and military and police for its ballistic protection. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.

Key Executives

  • Kim Kraig Thompson
  • Jonathan R. Rice
  • Kenneth Le
  • Xiaoli Zhang

Current Ownership Distribution

  • Other904.5M (81.26%)
  • Insiders207.4M (18.63%)
  • Institutions1.2M (0.11%)
  • Mutual Funds0 (0.00%)